HUVEC layer
compartment tissue
compartment culture
tissue culture
Adhesion assays
adhesion HUVEC
HUVEC adhesion
CD11a/CD18 ICAM-1
CD11a/CD18 interactions
ICAM-1 interactions
motility se
matrix components
alpha beta
beta alpha
alpha beta
alpha beta
beta alpha
alpha beta
glands alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha beta
alpha beta
beta ICAM-1
ICAM-1 VCAM-1
Endothelium alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha IIb
alpha IIb
beta adhesion
adhesion molecule
adhesion ICAM-1
molecule ICAM-1
types VCAM-1
VCAM-1 endothelium
arterioles venules
venules capillaries
staining E-selectin
arterioles venules
alpha alpha
alpha alpha
alpha alpha
alpha beta
alpha beta
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha alpha
alpha beta
alpha beta
beta adhesion
adhesion ICAM-1
adhesion L-selectin
ICAM-1 L-selectin
stromal glands
glands integrins
integrins membrane
membrane components
glycoproteins outgrowth
trophoblast vitro
adhesion trophoblast
trophoblast vitronectin
findings data
data adhesion
adhesion alpha
antigen-1 lymphocytes
antigen-1 ICAM-1
lymphocytes ICAM-1
ICAM-1 endothelium
CD56+ lymphocytes
integrins lymphocytes
ICAM-1 VCAM-1
retention stroma
intraocular neoplasm
intraocular inactivation
neoplasm inactivation
inactivation alleles
alleles RB1
alleles tumor
RB1 tumor
RB1 suppressor
RB1 gene
tumor suppressor
tumor gene
suppressor gene
RB1 carriers
carriers tumors
tumors Rb
Rb penetrance
penetrance expressivity
penetrance pedigrees
Arg661Trp mutation
mutation penetrance
penetrance mutations
penetrance Fishers
Fishers test:
penetrance alleles
involvement modifier
modifier gene
modifier penetrance
gene penetrance
gene Rb
penetrance Rb
MED4-driven MED4
MED4-driven methylation
MED4 methylation
MED4 analyses
methylation analyses
CpG85 intron
intron RB1
RB1 DNA
DNA methylation
differential methylation
1981C>T allele
Arg661Trp allele
Arg661Trp tumor
allele tumor
allele suppressor
tumor suppressor
suppressor retinoblastoma
1981C>T mutation
haploinsufficiency tumorigenesis
penetrance Rb
RB E2F
RB Myb
RB complex
E2F Myb
E2F complex
Myb complex
Drosophila Caenorhaditis
Drosophila elegans
Caenorhaditis elegans
cycle E2F-4
G0/G1 complexes
complexes transcription
transcription S/G2
S/G2 complex
papillomavirus E6
papillomavirus E7
papillomavirus oncoproteins
E6 E7
E6 oncoproteins
E7 oncoproteins
transformation cancer
role transformation
transformation cancer
hydrocarbon receptor
receptor proliferation
arrests cycle
cycle LoVo
cycle colon
LoVo colon
LoVo cancer
colon cancer
cancer AhR
AhR FICZ
FICZ AhR
AhR CYP1A1
AhR CDK4
AhR cyclin
CYP1A1 CDK4
CYP1A1 cyclin
CDK4 cyclin
CDK4 CDK2
cyclin CDK2
cyclin P27
CDK2 P27
CDK2 pRb
P27 pRb
activation AhR
AhR immunofluorescence
assay cytometric
assay analysis
cytometric analysis
viability cycle
cycle apoptosis
FICZ proliferation
analysis FICZ
down-regulation cyclinD1
down-regulation up-regulation
cyclinD1 up-regulation
co-treatment CH223191
AhR FICZ
FICZ endogenous
FICZ AhR
FICZ ligand
endogenous AhR
endogenous ligand
AhR ligand
immunosenescence outcomes
outcomes adults
Studies resveratrol
resveratrol activator
Human diploid
Human fibroblast
Human WI-38
diploid fibroblast
diploid WI-38
fibroblast WI-38
replication qPCR
β galactosidase
proteins proteins
proteins Rb
proteins p16
Rb p16
Rb p53
p16 p53
laboratory assays
activation mechanisms
mechanisms senescence
mechanisms ROS
senescence ROS
findings sirtinol
Mutations Ras
Mutations oncogene
Ras oncogene
defense tumorigenesis
tumorigenesis mechanisms
mechanisms Ras
senescent phenotype
Ras effector
Ras NORE1A
effector NORE1A
NORE1A role
role senescence
senescence Ras
p53 tumor
p53 suppressor
tumor suppressor
NORE1A Ras
prosenescent tumor
prosenescent retinoblastoma
tumor retinoblastoma
tumor protein
retinoblastoma protein
complex NORE1A
NORE1A PP1A
PP1A activation
activation Rb
activation tumor
Rb tumor
Rb suppressor
Rb dephosphorylation
tumor suppressor
tumor dephosphorylation
suppressor dephosphorylation
Furthermore Rb
Rb NORE1A
Rb senescence
NORE1A senescence
findings NORE1A
tumor suppressor
tumor node
tumor Ras
suppressor node
suppressor Ras
node Ras
Ras p53
p53 Rb
Rb senescence
TGFβ cytokine
mediator types
types tissues
autophagy tumor
tumor suppressor
TGFβ autophagy
activation autophagy
inhibitory TGFβ
autophagy cancer
maturation TGFβ
retinoblastoma tumor
retinoblastoma suppressor
retinoblastoma promoter
tumor suppressor
tumor promoter
suppressor promoter
tumor suppressive
TGFβ activation
activation genes
findings TGFβ
TGFβ autophagy
activation genes
downstream TGFβ
TGFβ tumor
hepatocellular carcinoma
pRb protein
genes RB1
genes RBL1
genes RBL2
RB1 RBL1
RB1 RBL2
RB1 RBL2
RBL1 RBL2
RBL1 RBL2
RBL1 promoter
RBL2 RBL2
RBL2 promoter
RBL2 promoter
RBL2 methylation
promoter methylation
methylation DNA
DNA methyltransferase
over-expression HCV
HCV HuH-7-CORE
HCV protein
protein protein
protein mRNA
protein levels
mRNA levels
mRNA HuH-7-CORE
levels HuH-7-CORE
HuH-7-CORE promoter
promoter hyper-methylation
hyper-methylation up-regulation
up-regulation DNMT1
up-regulation DNMT3b
DNMT1 DNMT3b
HuH-7-CORE cycle
HuH-7-CORE analysis
cycle analysis
RB tumor
tumor suppressor
pRb pRb2/p130
transformation HCV
immuno-histochemistry thymomas
thymomas carcinomas
thymomas %
thymomas thymic
% thymic
% carcinoma
thymic carcinoma
Expression pRb
HPyV7 phospho-Rb-
correlation p16
follicular hyperplasias
hyperplasias pRb
cycle proteins
cycle correlation
proteins correlation
pRb phospho-Rb
pRb p16
phospho-Rb p16
p16 thymic
thymic tumors
HPyV7 thymomagenesis
data pRb
data phospho-Rb
pRb phospho-Rb
HPyV7 thymomagenesis
O-GlcNAc transferase
O-GlcNAc O-GlcNAcase
transferase O-GlcNAcase
OGT/OGA protein
OGT and/or
OGT OGA
and/or OGA
pathologic cis
assay promoters
transcription sites
sites Ogt
E2F consensus
E2F sequences
consensus sequences
consensus promoters
sequences promoters
E2F1 E2F
E2F sites
sites promoters
HEK293 E2F1
E2F1 OGT
OGT MGEA5
E2F1-deficient fibroblasts
fibroblasts Ogt
Ogt Mgea5
E2F1 retinoblastoma
Rb1-deficient fibroblasts
fibroblasts levels
levels Ogt
levels Mgea5
Ogt Mgea5
Mgea5 overexpression
overexpression E2F1
E2F1 Rb1-deficient
Ogt Mgea5
Mgea5 Rb1
Rb1 E2F1-mediated
promoter Ogt
Ogt Mgea5
Ogt genes
Mgea5 genes
Specifically E2F1
E2F1 Ogt
Ogt Mgea5
Mgea5 Rb1
tumor suppressor
malignancies prostate
malignancies cancer
prostate cancer
Overexpression miR-449a
miR-449a cycle
cycle apoptosis
cycle senescence
apoptosis senescence
senescence role
role ionizing
ionizing radiation
G2/M apoptosis
apoptosis pRb/E2F1
pRb/E2F1 prostate
pRb/E2F1 cancer
prostate cancer
prostate X-ray
cancer X-ray
cancer radiation
X-ray radiation
Rb PC-3
Rb overexpression
PC-3 overexpression
PC-3 miR-449a
overexpression miR-449a
miR-449a G2/M
G2/M apoptosis
apoptosis sensitivity
sensitivity X-ray
sensitivity radiation
X-ray radiation
Rb DU-145
X-ray radiation
cycle DU-145
Furthermore downregulates
downregulates cycle
downregulates regulator
downregulates CDC25A
cycle regulator
cycle CDC25A
cycle oncogene
regulator CDC25A
regulator oncogene
regulator HDAC1
CDC25A oncogene
CDC25A HDAC1
oncogene HDAC1
cycle progression
cycle apoptosis
progression apoptosis
radiosensitivity PC-3
Rb radiosensitivity
radiosensitivity PC-3
PC-3 pRb/E2F1
protein roles
roles tumor
E3 ubiquitin
E3 ligases
ubiquitin ligases
RB E3
RB ubiquitin
RB ligase
E3 ubiquitin
E3 ligase
ubiquitin ligase
ubiquitin RB
ligase RB
NRBE3 LXCXE
NRBE3 motif
LXCXE motif
LXCXE RB
motif RB
RB vitro
NRBE3 RB
NRBE3 RB
NRBE3 ubiquitination
RB ubiquitination
Importantly NRBE3
NRBE3 RB
RB vitro
vitro U-box
Surprisingly NRBE3
NRBE3 cycle
cycle transition
cancer tissues
E3 ligase
E3 RB
ligase RB
role oncoprotein
oncoprotein cancers
subtypes osteosarcoma
subtypes gene
osteosarcoma gene
osteosarcoma profiling
gene profiling
tumor behavior
tumor outcomes
behavior outcomes
bioinformatic analyses
deregulation retinoblastoma
subtype outcomes
behavior subtype
role RB-E2F
prognostic gene
Ectopic RB
E2F gene
tumors outcomes
tumors outcomes
RB-E2F dysfunction
RB-E2F gene
dysfunction gene
gene osteosarcoma
DNA methyltransferase
DNA histone
DNA deacetylase
methyltransferase histone
methyltransferase deacetylase
histone deacetylase
data deregulation
deregulation RB-E2F
behavior osteosarcoma
protein p16
p16 pRB
pRB cancer
ER PR
ER HER-2
ER Ki-67
PR HER-2
PR Ki-67
HER-2 Ki-67
HER-2 fluorescent
Ki-67 fluorescent
Ki-67 situ
fluorescent situ
fluorescent hybridization
situ hybridization
situ HER-2
hybridization HER-2
p16 <
Alteration p16
Alteration p16
Ki67 labeling
Ki67 0
labeling 0
positivity PR
PR negativity
DFS analysis
Expression p16
p16 pRB
subgroups cancer
retinoblastoma tumor
retinoblastoma protein
tumor protein
protein chromatin
chromatin gene
Rb-dependent RNA
analysis RNA
colon Rb
protein products
protein Rb
proliferation transcription
Rb tissues
tissues decrease
decrease proteins
RB1 inactivation
Additionally RB/Rb
RB/Rb pyruvate
pyruvate oxidation
TCA cycle
TCA tissues
cycle tissues
proteomic analyses
Rb/RB1 mutation
retinoblastoma tumor
retinoblastoma suppressor
retinoblastoma protein
retinoblastoma pRb
tumor suppressor
tumor protein
tumor pRb
suppressor protein
suppressor pRb
protein pRb
inhibition cycle
inhibition progression
cycle progression
pRb differentiation
differentiation mechanisms
differentiation tumor
KDM5A demethylase
KDM5A 5A
demethylase 5A
demethylase histone
5A histone
5A H3
histone H3
histone Lys4
H3 Lys4
Lys4 protein
protein pRBs
protein role
pRBs role
pRBs differentiation
role differentiation
Kdm5a differentiation
network type-specific
type-specific genes
pRB cycle
cycle differentiation
cycle exit
Cells Rb1
Rb1 mitochondria
mitochondria oxygen
Kdm5a repressor
repressor genes
role Kdm5a
role deletion
Kdm5a deletion
Significantly activation
regulator Pgc-1α
regulator proliferator-activated
regulator receptor
Pgc-1α proliferator-activated
Pgc-1α receptor
Pgc-1α 1α
proliferator-activated receptor
proliferator-activated 1α
receptor 1α
coactivator Kdm5a
coactivator target
Kdm5a target
Kdm5a genes
target genes
Overexpression Pgc-1α
Overexpression KDM5A
Pgc-1α KDM5A
Pgc-1α deletion
KDM5A deletion
differentiation KDM5A
KDM5A activation
activation biogenesis
cancer phenotype
CNE-1 CNE-2
CNE-2 lentiviruses
radiosensitivity assay
BrdU incorporation
BrdU assay
incorporation assay
incorporation cytometry
assay cytometry
pRb Rb
pRb H3K9Me3
pRb HP1γ
pRb CDK4
Rb H3K9Me3
Rb HP1γ
Rb CDK4
Rb cyclin
H3K9Me3 HP1γ
H3K9Me3 CDK4
H3K9Me3 cyclin
H3K9Me3 D1
HP1γ CDK4
HP1γ cyclin
HP1γ D1
CDK4 cyclin
CDK4 D1
cyclin D1
CNE-1-scramble shRNA
CNE-1-scramble SHP-1
CNE-1-scramble downregulation
shRNA SHP-1
shRNA downregulation
SHP-1 downregulation
downregulation senescence
SHP-1 overexpression
overexpression inhibition
inhibition senescence
senescence cycle
Levels p53
Levels p21
p53 p21
SHP-1 role
role cycle
cycle progression
cycle senescence
progression senescence
patients NPC
retinoblastoma tumor
retinoblastoma suppressor
tumor suppressor
tumor cycle
suppressor cycle
suppressor progression
cycle progression
cycle E2F-responsive
progression E2F-responsive
progression transcription
E2F-responsive transcription
Cellular kinase
Cellular Rb
kinase Rb
kinase inactivation
Rb inactivation
Rb phosphorylation
inactivation phosphorylation
inactivation Rb-E2F
phosphorylation Rb-E2F
phosphorylation complexes
Rb-E2F complexes
Rb-E2F transcription
complexes transcription
cytomegalovirus UL97
cytomegalovirus protein
UL97 protein
protein CDK
CDK Rb
consensus CDK
consensus sites
consensus Rb
CDK sites
CDK Rb
sites Rb
Rb peptides
peptides acid
acid LXCXE
UL97 motifs
LXCXE motif
LXCXE UL97
motif UL97
UL97 Rb
Rb UL97-mediated
Rb Rb
UL97-mediated Rb
UL97-mediated phosphorylation
Rb phosphorylation
phosphorylation sites
Rb-E2F complexes
repression E2F
repression reporter
repression constructs
E2F reporter
E2F constructs
reporter constructs
protein UL97-L1m
UL97-L1m Rb
Rb transfection
Rb assays
transfection assays
E2F-responsive gene
mechanisms Rb
data UL97
E2F-dependent gene
gene disruption
disruption Rb-E2F
disruption complexes
Rb-E2F complexes
L1 motif
L1 UL97
motif UL97
Micron imaging
fundus photographs
fundus OCT
photographs OCT
OCT imaging
tumors OCT
discoid tumors
tumors periphery
OCT imaging
imaging modality
tumor vivo
Tracking tumor
therapeutics factors
Rb1 Pten
progenitor Chx10-Cre
Chx10-Cre Rbl1
vivo electroporation
vivo retinas
electroporation retinas
apoptosis tumor
proliferation apoptosis
proliferation activation
apoptosis activation
ShRNAs vitro
apoptosis gene
Pten Rb1
Pten Rbl1
Rb1 Rbl1
Rbl1 progenitor
Rb/E2F-induced apoptosis
apoptosis murine
apoptosis retina
murine retina
murine Rb/p107
retina Rb/p107
Rb/p107 Rb/E2F
Rb/p107 apoptosis
Rb/E2F apoptosis
apoptosis retinoblastoma
apoptosis emergence
retinoblastoma emergence
deletion Pten
signaling retinoblastoma
shRNA Akt
Akt phosphorylation
Akt targets
Akt FOXOs
phosphorylation targets
phosphorylation FOXOs
targets FOXOs
FOXOs mediators
mediators apoptosis
trigger E2F/FOXO
homeostasis retinoblastoma
homeostasis tumor
retinoblastoma tumor
frequency co-altered
co-altered RB/E2F
RB/E2F PTEN/PI3K/AKT
inhibitor kinases
cancer therapy
cancer strategy
therapy strategy
molecule inhibitors
molecule recruitment
inhibitors recruitment
recruitment Thr-187-phosphorylated
Thr-187-phosphorylated SCF
Thr-187-phosphorylated ubiquitin
SCF ubiquitin
SCF ligase
ubiquitin ligase
phosphorylation Thr-187
interaction p27
interaction Skp2/Cks1
p27 Skp2/Cks1
p27 tumor
Skp2/Cks1 tumor
Skp2/Cks1 susceptibility
tumor susceptibility
tumor proliferation
susceptibility proliferation
proliferation physiology
Rb1 tumors
tumors penetrance
penetrance tumors
tumors Rb1
tumors modeling
Rb1 modeling
RB1 humans
p27T187A KI
p27T187A tumorigenesis
KI tumorigenesis
tumorigenesis Rb1
findings contexts
ubiquitination SCF
ubiquitination ubiquitin
ubiquitination ligase
SCF ubiquitin
SCF ligase
ubiquitin ligase
potentials Skp2/Cks1-p27T187p
potentials interaction
potentials inhibitors
Skp2/Cks1-p27T187p interaction
Skp2/Cks1-p27T187p inhibitors
interaction inhibitors
protein levels
Cyclins/retinoblastoma protein
roles hypertrophy
miRNAs hypertrophy
cardiomyocyte hypertrophy
aortic constriction
transverse aortic
transverse constriction
aortic constriction
ventricular cardiomyocyte
ventricular cardiomyocyte
myocardium cardiomyocytes
hypertrophy phenotype
phenotype cardiomyocytes
cardiomyocytes inhibition
cardiomyocytes miR-16
inhibition miR-16
miR-16 phenotype
phenotype cardiomyocytes
Expressions cyclins
Expressions D1
Expressions D2
cyclins D1
cyclins D2
cyclins E1
D1 D2
D1 E1
D2 E1
E1 pRb
pRb hypertrophic
hypertrophic myocardium
hypertrophic cardiomyocytes
myocardium cardiomyocytes
Cyclins D1
Cyclins D2
Cyclins E1
D1 D2
D1 E1
D2 E1
transducer activator
activator c-Myc
hypertrophy inhibitions
hypertrophy cyclins
cyclins D1
cyclins D2
cyclins E1
D1 D2
D1 E1
D2 E1
miR-16 target
target hypertrophy
Cellular iPSCs
tumor suppressors
tumor factors
suppressors factors
tumor suppressor
suppressor repressor
repressor Sox2
repressor differentiation
Sox2 differentiation
repression Sox2
Sox2 tumor
retinoblastoma proteins
proteins pRb
regulators cycle
cycle tumor
cycle suppressor
tumor suppressor
suppressor roles
roles differentiation
deletion Rb
deletion p130
Rb p130
p130 repression
repression Sox2
repression deffect
Sox2 deffect
deffect inactivation
inactivation p53
reprogramming impact
impact repression
repression Sox2
Sox2 Rb
repression pRb
immunocytochemistry PCR
cancer tissue
tissue nontumor
nontumor tissues
Statistical analyses
role TBLR1
role proliferation
TBLR1 proliferation
TBLR1 tumorigenicity
proliferation tumorigenicity
tumorigenicity cancer
vitro vivo
cyclin D1
cyclin signaling
D1 signaling
reporter assay
assay immunoprecipitation
immunoprecipitation techniques
cancer tissues
survival patients
patients TBLR1
TBLR1 survival
analysis TBLR1
indicator survival
survival cancer
survival patients
cancer patients
TBLR1 overexpression
TBLR1 TBLR1
overexpression TBLR1
TBLR1 proliferation
proliferation tumorigenicity
tumorigenicity cancer
cancer vitro
vitro vivo
upregulation D1
upregulation phosphorylation
D1 phosphorylation
phosphorylation protein
protein Rb
protein activation
Rb activation
activation signaling
signaling cancer
TBLR1 role
progression cancer
cancer cyclin
cancer D1-transactivation
cyclin D1-transactivation
cyclin activation
D1-transactivation activation
prognostic marker
mechanisms diseases
cancer mutations
mutations retinoblastoma
mutations gene
retinoblastoma gene
gene mutagenesis
mutations sites
tumor spectrum
tumor incidence
spectrum incidence
Rb1 knockout
Rb1 pituitary
Rb1 tumors
pituitary tumors
pituitary thyroid
pituitary tumors
tumors thyroid
tumors tumors
thyroid tumors
analyses tissue
tissue E2F1
E2F1 E2F2/3
Rb protein
Rb tumors
protein tumors
tumors E2F1
Rb1 tumors
lobe pituitary
pituitary inactivation
inactivation E2F1
Furthermore lobe
pRb inactivation
inactivation E2F
reconstitution assay
reconstitution proteins
assay proteins
D326V missense
D326V pRb
missense pRb
missense E2F1
pRb E2F1
E2F impact
impact protein
protein tumorigenesis
Rb mutations
retinoblastoma corepressors
cycle senescence
cycle differentiation
senescence differentiation
stability proteins
Previously protein
protein turnover
Drosophila protein
Drosophila Rbf1
protein Rbf1
protein proteins
Rbf1 proteins
proteins stability
protein impact
impact kinase
kinase Rbf1
threonine residue
impact turnover
residues C-terminal
residues IE
C-terminal IE
C-terminal Rbf1
IE Rbf1
Rbf1 turnover
Strikingly IE
Strikingly mutations
IE mutations
IE turnover
mutations turnover
phenotypes Drosophila
Lys-774 residue
Lys-774 phenotypes
residue phenotypes
phosphorylation mutation
mutation codon
lung tumors
residues IE
IE protein
IE turnover
protein turnover
protein interactions
turnover interactions
interactions E3
interactions ligases
E3 ligases
E3 protein
ligases protein
protein contacts
contacts E2F
contacts transcription
E2F transcription
RB proteins
proteins implications
PI3K inhibitors
drug PIK3CA
PIK3CA cancers
cancers sensitivity
sensitivity PI3K
sensitivity inhibitors
PI3K inhibitors
inhibitors CDK
CDK 4/6-PI3K
CDK inhibition
4/6-PI3K inhibition
inhibition viability
cancers RB
cancers phosphorylation
RB phosphorylation
PI3K inhibitors
PI3K cancers
inhibitors cancers
cancers sensitivity
patients tumors
PI3K inhibitor
PI3K BYL719
inhibitor BYL719
BYL719 pRB
pRB nonresponding
pRB tumors
nonresponding tumors
levels pRB
PI3K CDK
PI3K inhibitors
CDK inhibitors
tumor regressions
tumor PIK3CA
regressions PIK3CA
regressions xenografts
PIK3CA xenografts
fucoidan HepG2
Fucoidan HepG2
HepG2 viability
viability apoptosis
Furthermore upregulation
Furthermore p16
upregulation p16
HepG2 fucoidan
inhibition Cdk4
inhibition pRb
Cdk4 pRb
Cdk4 upregulation
pRb upregulation
fucoidan INK4a
fucoidan locus
fucoidan genes
INK4a locus
INK4a genes
locus genes
locus apoptosis
genes apoptosis
apoptosis MAPK
MAPK HepG2
senescence hepatic
fucoidan tumor
cycle progression
segregation chromosomes
mitotic kinase
Inhibition Aurora
Aurora stabilization
stabilization p53
genes p21
p21 proliferation
p21 p53
p21 inhibition
p53 inhibition
p53 Aurora
inhibition Aurora
MAPK elongation
elongation p21
elongation RNA
p21 RNA
p21 Pol
RNA Pol
subset genes
inhibition Aurora
inhibition Aurora
Aurora down-regulation
down-regulation E2F-mediated
down-regulation transcription
E2F-mediated transcription
cycle Aurora
Aurora inhibition
inhibition p53
p53 tumor
p53 suppressor
tumor suppressor
activation p21
activation inhibition
p21 inhibition
p21 Aurora
inhibition Aurora
chromosome missegregation
chromosome aneuploidy
missegregation aneuploidy
aneuploidy binucleation
binucleation tetraploidy
reactive oxygen
reactive p38
oxygen p38
oxygen MAPK
p38 MAPK
inhibitors Aurora
Aurora inhibition
Aurora inhibitors
inhibitors therapy
therapy cancer
effectiveness therapy
effectiveness patients
therapy patients
squamous carcinoma
HNSCC pathogenesis
cancers cancer
cancer progression
relevance mechanisms
HNSCC progression
